LAP3 is one member of the LAPs and has been reported to be upregulated in diverse cancer types, such as ovarian cancer, glioma, esophageal squamous cell carcinoma and hepatocellular carcinoma [21–25]. Here, LAP3 is linked to ovarian carcinoma.